New chromatin‑based analysis of 1,563 AML samples reveals 16 epigenomic subgroups that improve prognostic accuracy and highlight unexpected drug sensitivities. The post Epigenomic Analysis Uncovers New AML Subgroups and Drug Sensitivities appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.